WallStreetZenWallStreetZen

NASDAQ: VKTX
Viking Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Viking Therapeutics earnings were -$534.8M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest VKTX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$128.0M, down 19.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, VKTX reported annual earnings of -$359.6M, with 227.1% growth.

VKTX earnings history

Current Revenue
$0.0
Current Earnings
-$534.8M
Current Profit Margin
0%

VKTX Return on Equity

Current Company
-94.6%
Current Industry
4.3%
Current Market
39.7%
VKTX's Return on Equity (-94.6%)... subscribe to Premium to read more.
High Return on Equity Performance

VKTX Return on Assets

Current Company
-82.7%
Current Industry
-0.8%
VKTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when VKTX announces earnings.

VKTX Return on Capital Employed

Current Company
-129.73%
Current Industry
1.8%
VKTX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VKTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
VKTX-$534.35M-$534.80MN/A-$4.67
VCYT$115.05M$88.01M+158.14%$1.11
DNLI-$492.55M-$508.02MN/A-$2.88
ADPT-$15.48M-$49.68MN/A-$0.33
RLAY-$269.85M-$272.71MN/A-$1.56
View Top Biotech Stocks

Viking Therapeutics Earnings Reports & History FAQ

What were Viking Therapeutics's earnings last quarter?

On VKTX's earnings call on Jul 29, 2026, Viking Therapeutics (NASDAQ: VKTX) reported Q2 2026 earnings per share (EPS) of -$1.10, up 89.66% year over year. Total VKTX earnings for the quarter were -$128.02 million. In the same quarter last year, Viking Therapeutics's earnings per share (EPS) was -$0.58.

If you're new to stock investing, here's how to buy Viking Therapeutics stock.

Is Viking Therapeutics profitable or losing money?

As of the last Viking Therapeutics earnings report, Viking Therapeutics is currently losing money. Viking Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$534.80 million, a 211.75% increase year over year.

What was VKTX's earnings growth in the past year?

As of Viking Therapeutics's earnings date in Jul 29, 2026, Viking Therapeutics's earnings has grown year over year. VKTX earnings in the past year totalled -$534.80 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.